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INTRODUCTION
Amyloidosis is a multisystemic disease characterized by 
extracellular deposition of abnormal fibrillar proteins in 
organs [1]. Amyloid deposition in heart muscles causes 
cardiac amyloidosis (CA), a leading cause of morbidity and 
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feature tracking strain values were compared in an intergroup and interregional manner.
Results: Of the patients with CA, 32 had diffuse global LGE (group 2), and 8 had focal patchy or no LGE (group 1). Global 
native T1, T2, and ECV were significantly higher in groups 1 and 2 than in the control group (native T1: 1384.4 ms vs. 1466.8 
ms vs. 1230.5 ms; T2: 53.8 ms vs. 54.2 ms vs. 48.9 ms; and ECV: 36.9% vs. 51.4% vs. 26.0%, respectively; all, p < 0.001). 
Basal ECV (53.7%) was significantly higher than the mid and apical ECVs (50.1% and 50.0%, respectively; p < 0.001) in group 
2. Basal and mid peak radial strains (PRSs) and peak circumferential strains (PCSs) were significantly lower than the apical 
PRS and PCS, respectively (PRS, 15.6% vs. 16.7% vs. 26.9%; and PCS, -9.7% vs. -10.9% vs. -15.0%; all, p < 0.001). Basal ECV 
and basal strain (2-dimensional PRS) in group 2 showed a significant negative correlation (r = -0.623, p < 0.001). Group 1 
showed no regional ECV differences (basal, 37.0%; mid, 35.9%; and apical, 38.3%; p = 0.184).
Conclusion: Quantitative T1 mapping parameters such as native T1 and ECV may help diagnose early CA. ECV, in particular, 
can reflect regional differences in the amyloid deposition in patients with advanced CA, and increased basal ECV is related 
to decreased basal strain. Therefore, quantitative CMR parameters may help diagnose CA and determine its severity in 
patients with or without LGE. 
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mortality [2,3].
Features of CA include global circumferential late 
gadolinium enhancement (LGE) patterns on cardiac magnetic 
resonance (CMR) imaging [4]. However, LGE patterns are 
not always visible and may be atypical or patchy [5-7]. 
Moreover, LGE imaging is sometimes challenging in patients 
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retrospective study and waived the requirement for informed 
consent (IRB No. 4-2019-1269). Between March 2012 and 
December 2018, patients who underwent CMR imaging at 
our institution were searched. 
The inclusion criteria were as follows: 1) endomyocardial 
biopsy (EMB) demonstrating amyloidosis in the 
myocardium, or 2) positive noncardiac biopsy or DNA test 
results for amyloidosis and echocardiographic evidence of 
left ventricular (LV) wall thickening (mean LV thickness 
of the septum and posterior wall > 12 mm) and diastolic 
dysfunction [22]. Patients suspected of having other cardiac 
diseases were excluded. Fifteen controls without any history 
in our CMR registry were reviewed. Figure 1 explains our 
patient selection process. The patients’ functional states 
were assessed using the New York Heart Association (NYHA) 
functional classifications [23]. We also investigated low-
voltage on the electrocardiogram (ECG). 
CMR Protocol
All subjects underwent CMR with a 3T scanner (Magnetom 
Trio Tim, Siemens Healthineers) using a 6-element body 
matrix coil and spine matrix coil array. Two-chamber, 
4-chamber, and short-axis (SA) cine images were acquired 
using a retrospectively ECG-gated, balanced steady-
state free precession (true fast imaging with steady-state 
precession [TrueFISP]) sequence. Supplementary Materials 
summarizes these parameters.
T1 mapping images were acquired before contrast 
injection in 3 SA planes (basal, mid, and apical LV) using a 
modified look-locker inversion-recovery (MOLLI) sequence 
at the end-expiratory phase. A nonselective inversion pulse 
(TrueFISP single-shot readout sequence in the mid-diastolic 
with CA owing to diffuse amyloid deposition throughout the 
heart, causing incorrect nulling [8]. CA shows a regional 
apical sparing pattern on 2-dimensional (2D) speckle 
tracking echocardiographic strain imaging [4,9]. These 
features help diagnose CA; however, they are not always 
found and are usually visible only in advanced CA [9,10]. 
The origin of the apical-sparing pattern of longitudinal 
strain in CA is not fully understood but may be related to 
lower amyloid burden in apical segments [11].
CMR is becoming the preferred imaging technique for 
the diagnosis of CA [12-16]. T1 mapping, an emerging 
technique, provides an objective means of diagnosing CA 
[4]. Native T1 and extracellular volume (ECV) are useful 
surrogate markers of amyloid burden in CA [3,12,13,16-
20]. CMR-feature tracking (FT) is another evolving method 
for the analysis of quantitative myocardial mechanics using 
routine cine images [15,21]. These quantitative parameters 
can objectively show regional and global abnormalities 
compared with conventional qualitative LGE image analysis. 
We assumed that quantitative mapping and FT parameters 
would be useful for noninvasive global and regional amyloid 
deposition evaluation in the myocardium and may show 
different regional distribution patterns in patients with 
early and advanced CA. 
This study aimed to investigate the regional amyloid 
burden and myocardial deformation using T1 mapping and 
strain values in patients with CA according to LGE patterns.
MATERIALS AND METHODS
Patients
Our Institutional Review Board approved this 
Fig. 1. Patient selection. LGE = late gadolinium enhancement, LV = left ventricular, n = number of patients
Patients with cardiac MRI (n = 42)
1) An endomyocardial biopsy demonstrates amyloidosis in the myocardium
2)  A noncardiac biopsy is positive for amyloidosis and there is echocardiographic evidence  
of a thickened LV wall
Exclusion
• Combined other myocardial disease (n = 2)
Group 1 (n = 8)
Focal patchy or no LGE
Group 2 (n = 32)
Diffuse and global LGE




phase) was employed using the following parameters: field 
of view (FOV), 306 x 360 mm; acquisition matrix, 144 x 256 
pixels; slice thickness (ST), 8 mm; repetition time (TR), 2.2 
ms; echo time (TE), 1.1 ms; minimum inversion time, 100 
ms; inversion time increment, 80 ms; flip angle (FA), 35°; 
parallel acquisition technique factor, 2; and the number of 
inversions, 2 [“5,(3),3” sequence]. Fully automated, non-
rigid motion correction was applied to register individual 
T1 images before inline T1 fitting was performed using a 
monoexponential 3-parameter fit.
T2 mapping images were acquired before contrast 
injection using a T2-prepared, single-shot TrueFISP 
sequence along the same planes used for T1. The parameters 
were: TR/TE, 2.1/1.1 ms; FA, 70°; bandwidth, 930 Hz/
pixel; FOV, 379 x 308 mm2; matrix, 192 x 126 pixels; ST, 8 
mm; GeneRalized Autocalibrating Partial Parallel Acquisition 
(GRAPPA) factor, 2, with the acquisition on every fourth 
heartbeat; and T2 preparation times, 0, 25, and 55 ms. T2 
pixel maps were generated by fitting pixel intensities onto a 
2-parameter monoexponential signal model after automatic 
in-plane, non-rigid motion correction. 
Post-contrast T1 mapping images were acquired 13 
minutes after intravenous injection of 0.2 mmol/kg of 
gadolinium contrast (meglumine gadoterate [Dotarem], 
Guerbet) along the same 3 SA planes used for T1. The 
scheme for post-contrast T1 mapping was “4(1)3(1)2” using 
3 inversion pulses.
Before post-contrast T1 mapping image acquisition, 
LGE CMR images were acquired 10 minutes after contrast 
injection using a magnitude- and phase-sensitive inversion-
recovery-prepared TrueFISP sequence with the inversion time 
adjusted to null, thus representing a normal myocardium. 
These LGE images were obtained along the same axis plane, 
covering the entire LV. Supplementary Materials summarizes 
these imaging parameters. The inversion time before LGE 
CMR imaging was determined using the fast low-angle shot 
sequence with varying inversion times (150 ms to 650 ms 
to null). Hematocrit levels were checked the day before CMR 
imaging.
CMR Image Analysis
Two expert radiologists (4 and 12 years of experience) 
analyzed the CMR images without the patients’ clinical 
information. After visual assessment and consensus between 
the radiologists, patients were divided into 2 subgroups: 
group 1 (focal patchy or no LGE; images showed non-
diffuse, discrete areas of LGE) (Fig. 2) and group 2 (diffuse 
and global LGE; images showed diffuse subendocardial or 
transmural circumferential patterns) [24]. 
Other image analyses were performed using the cvi42 
MR analysis software (Circle Cardiovascular Imaging Inc.). 
For functional analysis, LV wall endocardial and epicardial 
borders were delineated manually on end-diastolic and 
end-systolic images on SA cine images. Left ventricular 
ejection fraction (LVEF) and LV mass were automatically 
calculated. LV wall thickness was measured at the septum 
and inferolateral wall at the end-diastolic phase; the mean 
value was used for analysis. 
For native and post-contrast T1 and T2 mapping image 
analysis, mapping values were measured in 16 segments, 
excluding the apical segments. LV wall endocardial and 
epicardial borders were delineated manually and divided 
into 6 or 4 segments semiautomatically (Fig. 2). The 
myocardial edges were excluded by applying a 10% offset 
to minimize the partial volume artifact. LV blood pool T1 
values were measured using a circular region of interest 
> 10 mm2, avoiding the papillary muscle. Myocardial ECV 
was calculated with the following equation using the LV 
myocardium and blood pool native and post-contrast T1 
values and hematocrit values:
ECV (%) =  (ΔR1 of myocardium/ΔR1 of LV blood pool) x  
(1 - hematocrit) x 100
R1 = 1/T1, ΔR1 = (post-contrast R1-pre-contrast R1), 
The global native T1 (ms), ECV (%), and T2 (ms) were the 
mean values of the 16 LV segments. The basal, mid, and 
apical native T1, ECV, and T2 were the mean values of the 
6 basal LV segments, 6 mid LV segments, and 4 LV apical 
segments, respectively. 
CMR-FT Analysis
For the FT analysis, the 2-chamber, 4-chamber, and 
SA cine images were loaded onto the software. The 
LV endocardial and epicardial borders were delineated 
semiautomatically. Global 2D peak longitudinal strain 
(PLS), regional (basal, mid, apical) 2D peak radial strain 
(PRS), and 2D peak circumferential strain (PCS) values 
were obtained. Comparisons were performed using absolute 
values, as negative values implied strain direction.
Echocardiography
In patients with CA, transthoracic echocardiography 
was performed before CMR. Echocardiographic LVEF was 
determined using the biplane method of disk summation 
(modified Simpson’s rule) [25]. LV diastolic dysfunction was 
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Shapiro-Wilk test. ANOVA was used to evaluate global 
native T1, T2, and ECV and strain parameter differences 
across the 3 groups. We corrected the significance level 
using the Bonferroni adjustment for post-hoc analysis. 
Differences between the groups and regions (basal vs. 
mid vs. apical) were evaluated with a linear mixed model 
that included random effects for subjects, to consider 
multiple measurements per subject, and fixed effects for 
evaluated using the fraction of early diastolic mitral inflow 
velocity/early diastolic mitral annular velocity (E/E’) [26].
Statistical Analysis
Categorical baseline characteristics were expressed as 
numbers and percentages and continuous variables as mean 
values and standard deviations or medians with interquartile 
















































Fig. 2. Cardiac MRI of patients. 
A patient in group 1 showing focal patchy LGE (arrow) at the mid ventricular inferolateral wall (A). A patient in group 2 showing diffuse global 
LGE (E). Mapping and ECV values were obtained using a software (Circle Cardiovascular Imaging Inc.). The endocardial and epicardial borders 
of the left myocardium were delineated manually and divided into 16 segments according to the recommendations of the AHA. ECV values were 
automatically calculated using the software. The measurement of mapping and ECV values of a patient in group 1 (B, C, D) and a patient in 




group, region, and interaction between group and region. 
Comparison analyses were also performed between the 
types of amyloidosis. Pearson’s or Spearman’s correlation 
coefficients were calculated to assess correlations between 
ECV and strain values. Statistical tests were 2-sided, and p < 
0.050 was considered significant. Statistical analyses were 
performed using SAS (version 9.4, SAS Institute Inc.).
RESULTS
Patients
Forty patients with CA were included in this study. 
Seventeen patients had EMB-confirmed CA. Twenty-three 
had CA confirmed by noncardiac biopsy (liver, 4; kidney, 
7; abdominal fat, 2; stomach, 1; bone marrow, 8) or DNA 
test (n = 1), and the presence of a thickened LV wall or 
diastolic dysfunction, without any other known cause for LV 
thickening. Of the 40 patients, 32 had amyloid light-chain 
(AL) amyloidosis, 6 had transthyretin (TTR) amyloidosis, 
and 2 had other types of amyloidosis. AL amyloidosis 
was confirmed by serum-free light-chain levels and bone 
marrow biopsy. TTR amyloidosis was confirmed by 99m 
pyrophosphate scans. 
Using LGE patterns, 32 patients were classified into 
group 2 and 8 into group 1. All group 2 patients showed 
LGE patterns typical of CA (diffuse circumferential LGE from 
endocardium to epicardium). Three group 1 patients showed 
no LGE, and 5 showed focal LGE (involving 1 segment in 
2 patients, 2 segments in 2 patients, and 3 segments in 1 
patient). Table 1 summarizes the baseline characteristics 
of the groups. Group 2 had significantly lower LVEF (50.4 
± 12.8%) than group 1 and the control group (70.1 ± 
6.1% and 65.1 ± 5.4%, respectively). Group 2 showed 
significantly higher LV wall thickness and LV mass than 
group 1 (thickness: 15.3 mm vs. 13.5 mm; mass: 98.3 g/m2 
vs. 73.4 g/m2, respectively). Only group 2 included patients 
with NYHA functional class ≥ III (7 patients, 21.9%, 
p = 0.070). Groups 1 and 2 had similar low-voltage ECG 
frequencies (75.0% vs. 78.1%, p = 0.658). 
T1 and T2 Mapping Parameters 
Intergroup Difference
Table 2 summarizes the mapping and ECV values of the 3 
groups. Global native T1 and ECV were significantly different 
across the groups. The values were significantly higher in 
group 2 (1466.8 ms and 51.4%, respectively) than in group 
1 (1384.4 ms and 36.9%, respectively) and the control 
group (1230.5 ms and 26.0%, respectively; p < 0.001). 
The values were significantly higher in group 1 than in the 
control group (all, p < 0.001). The global T2 in groups 1 
and 2 were higher than in the control group (53.8 ms vs. 
54.2 ms vs. 48.9 ms, respectively; p = 0.001). There was no 
statistically significant difference in the global T2 between 
groups 1 and 2. 
Table 1. Baseline Characteristics and Functional Parameters of the Study Population
Control (n = 15) Group 1 (n = 8) Group 2 (n = 32) P 
Sex, male (%) 10 (66.7) 5 (62.5) 21 (65.6) 0.980
Age (years) 54.9 ± 6.5 62.4 ± 11.0 63.2 ± 14.2 0.093
BSA (m2)* 1.73 ± 0.17 1.64 ± 0.13 1.57 ± 0.18 0.020
NT-ProBNP (pg/mL)§ NA 1340.0 (114.0–35000.0) 3693.0 (1434.0–5939.0) 0.655
LVEF (%)*† 65.1 ± 5.4 70.1 ± 6.1 50.4 ± 12.8 < 0.001
LVEDVI (mL/m2) 74.01 ± 18.1 72.62 ± 27.1 74.04 ± 16.39 0.981
LVESVI (mL/m2)*† 26.42 ± 9.86 21.80 ± 9.27 37.36 ± 14.34 0.003
LV wall thickness (mm)*†‡ 7.9 ± 0.4 13.5 ± 0.8 15.3 ± 2.1 < 0.001
LV mass index (g/m2)*† 55.5 ± 9.8 73.4 ± 15.1 98.3 ± 24.8 < 0.001
E/E’† NA 10.5 (9–12.8) 27.5 (18.0–33.5) < 0.001
NYHA class ≥ III 0 (0) 0 (0) 7 (21.9) 0.070
Low-voltage ECG NA 6 (75) 25 (78.1) 0.658
Unless otherwise indicated, data are presented as mean ± standard deviation or median (25–75th interquartile ranges). *Statistical 
significance between groups 2 and the control group, †Statistical significance between group 1 and 2, ‡Statistical significance 
between group 1 and control groups, §NT-ProBNP values were available for 27 patients in group 2. BSA = body surface area, ECG = 
electrocardiogram, E/E’ = ratio of early mitral inflow velocity to mitral annular early diastolic velocity, LV = left ventricular, LVEDV = LV 
end-diastolic volume, LVEF = LV ejection fraction, LVESV = LV end-systolic volume, NA = not available, NT-ProBNP = N-terminal pro b-type 
natriuretic peptide, NYHA = New York Heart Association 
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all, p > 0.050). There were no interregional native T1 and 
T2 differences in any group (all, p > 0.050).
CMR-FT Analysis
Intergroup Differences
The absolute values of all strain parameters were 
significantly lower in group 2 than in group 1 and the 
control group (-9.2% vs. -14.5% vs. -18.1% in global 
longitudinal strains, respectively; all, p < 0.001) (Table 3).
Interregional Difference
The control group’s apical ECV (28.8%) was higher than 
its basal and mid ECVs (25.9% and 25.8%, respectively), 
which is a known feature [27]. In group 2, there was a 
reverse pattern of ECV differences between the basal, mid, 
and apical regions (p < 0.001) (Fig. 3). The basal ECV 
(53.7%) was significantly higher than the mid and apical 
ECVs (50.1% and 50.0%, respectively). 
In group 1, there were no significant interregional ECV 
differences (basal: 37.0%, mid: 35.9%, and apical: 36.9%; 
Table 2. Myocardial Tissue Characterization by Cardiac Magnetic Resonance Imaging 
Control (n = 15) Group 1 (n = 8) Group 2 (n = 32) P
Native T1 (ms)
Basal*†‡ 1221.0 (1197.9,1244.0) 1384.8 (1343.1, 1426.52) 1472.1 (1443.7,1500.5) < 0.001
Mid*†‡ 1222.0 (1194.0, 1250.1) 1379.0 (1302.3, 1455.7) 1454.9 (1414.8, 1495.1) < 0.001
Apical*†‡ 1248.6 (1244.4, 1285.8) 1389.4 (1330.0, 1448.7) 1473.5 (1432.8, 1514.1) < 0.001
Global*†‡ 1230.5 (1203.1, 1258.0) 1384.4 (1328.9, 1439.9) 1466.8 (1433.3, 1500.3) < 0.001
ECV (%)
Basal*†‡ 25.9 (24.1, 27.6) 37.0 (33.0, 41.0) 53.7 (50.5, 57.0) < 0.001
Mid*†‡ 25.8 (27.0, 30.6) 35.9 (31.1, 40.7) 50.1 (46.9, 53.3) < 0.001
Apical*†‡ 28.8 (27.0, 30.6) 38.3 (33.1, 43.6) 50.0 (47.0, 53.0) < 0.001
Global*†‡ 26.0 (24.9, 27.0) 36.9 (32.4, 41.4) 51.4 (48.3, 54.5) < 0.001
T2 (ms)
Basal†‡ 48.9 (46.7, 51.0) 53.6 (51, 56.2) 53.9 (52.4, 55.4) 0.001
Mid†‡ 48.7 (45.6, 51.7) 53.3 (50.7, 56) 54.1 (52.5.55.6) < 0.001
Apical†‡ 49.9 (46.8, 53.0) 54.4 (51.8, 57) 54.7 (53.2, 56.2) < 0.001
Global†‡ 48.9 (46.9, 51.0) 53.8 (51.5, 56.1) 54.2 (52.8, 55.6) 0.001
Data are presented as mean (95% confidence interval). *Statistical significance between groups 1 and 2, †Statistical significance 
between group 1 and the control group, ‡Statistical significance between group 2 and the control group. ECV = extracellular volume
Fig. 3. Three regional ECV, native T1, and T2 values of 3 groups. 
A. Regional ECV values across the 3 groups. In the 3 regions, ECV is the highest in group 2, followed by group 1 and the control group. Regional 
differences show that in group 2, basal ECV was significantly higher than mid and apical ECVs (both, p < 0.001). In group 1, there was no 
regional difference. In the control group, apical ECV was higher than basal and mid ECVs. There were significantly different regional patterns 
between the groups and segments (p < 0.001). B. Regional native T1 values across the 3 groups. In the 3 regions, native T1 is the highest in 
group 2, followed by group 1 and the control group. There were no significant differences in the regional patterns across the groups and regions 
(p = 0.855). C. Regional T2 values across the 3 groups. In the 3 regions, T2 is the highest in group 2, followed by group 1 and the control group. 


















































Significant interregional strain pattern differences were 
found in group 2 (p < 0.001). Basal and mid 2D PRSs were 
significantly lower than the apical 2D PRS (basal vs. mid 
vs. apical: 15.6% vs. 16.7% vs. 26.9%; all, p < 0.001). 
There were no significant interregional 2D PRS differences 
in group 1 (basal vs. mid vs. apical: 45.8% vs. 42.3% vs. 
47.3%; p = 0.263).
2D PCS showed a similar pattern. In group 2, basal and 
mid 2D PCSs were significantly lower than apical 2D PCS 
(basal vs. mid vs. apical: -9.7% vs. -10.9% vs. -15%; p < 
0.001). There were no significant interregional differences 
in 2D PCS in group 1 (basal vs. mid vs. apical: -19.2% vs. 
-20.5% vs. -21.8%; p = 0.234). 
Correlation between ECV and Functional Parameters 
In group 2, there were positive correlations between basal 
2D PRS and basal ECV and between 2D PCS and basal ECV  
(r = -0.623 and r = -0.607, respectively) (Supplementary 
Table 1). The strain parameters of the mid and apical 
regions and ECV were not significantly correlated in group 
2. In group 1 and the control group, most strain parameters 
were not significantly correlated with ECV.
Comparison between the Types of Amyloidosis
Supplementary Table 2 summarizes the mapping and ECV 
values of the AL and TTR groups. There were no significant 
differences in native T1, T2, and ECV across the groups 
(all, p > 0.050). A significant interregional difference was 
observed in the AL group (p = 0.004), but not in the TTR 
group (p = 0.220). In the AL group, basal ECV (51.3%) was 
significantly higher than mid and apical ECVs (48.3% and 
48.9%, respectively; p = 0.004). In the TTR group, basal ECV 
(55.1%) was also higher than mid and apical ECVs (52.0% 
and 51.3%, respectively); however, there was no significant 
interregional difference (p = 0.220).
DISCUSSION
This study evaluated regional and global amyloid burden 
and strain patterns using quantitative CMR parameters in 
patients with CA, who were divided into 2 groups according 
to the LGE pattern. Native T1 and ECV were useful in 
diagnosing early CA, even when there was focal patchy or 
no LGE. Additionally, patients with advanced CA and diffuse 
LGE showed a characteristic “basal predominant pattern” in 
terms of both ECV and CMR strain values. 
We included 40 patients with CA based on previous 
criteria [22]. CA was diagnosed if an EMB demonstrated 
amyloidosis in the myocardium or if echocardiographic 
evidence of CA was found in a patient with a positive 
noncardiac biopsy result [22,28]. Echocardiographic features 
of CA include an LV wall thickness > 12 mm and no other 
potential causes of LV hypertrophy [22,29]. Although EMB 
is the gold standard for diagnosing many cardiomyopathies, 
it has limitations, including procedural risk and sampling 
error potential. Therefore, in clinical practice, CA diagnoses 
are often made via noncardiac biopsies and noninvasive 
imaging techniques.
CMR imaging is a well-established, noninvasive 
method for diagnosing CA with a characteristic global 
subendocardial LGE on the LV myocardium [30,31]. 
Table 3. Strain Parameters by Feature Tracking 
Control (n = 15) Group 1 (n = 8) Group 2 (n = 32) P 
2D PRS (%) 
Basal*† 40.5 (35.7, 45.2) 45.8 (39.3, 52.3) 15.6 (12.5, 18.6) < 0.001
Mid*† 40.2 (35.5, 44.8) 42.3 (35.1, 49.6) 16.7 (13.7, 19.8) < 0.001
Apical*† 53.4 (46.4, 60.4) 47.3 (35.9, 58.7) 26.9 (23.8, 29.9) < 0.001
Global*† 41.8 (37.9, 45.7) 44.2 (38.4, 49.9) 19.9 (17.1, 22.6) < 0.001
2D PCS (%) 
Basal*† -19.8 (-21.5, -18.1) -19.2 (-21.9, -16.6) -9.7 (-11.1, -8.2) < 0.001
Mid*† -21.2 (-22.8, -19.5) -20.5 (-23.1, -17.9) -10.9 (-12.3, -9.5) < 0.001
Apical*† -24.4 (-26.1, -22.6) -21.8 (-24.4, -19.1) -15 (-16.4, -13.5) < 0.001
Global*† -20.7 (-22.7, -18.7) -20.8 (-23.1, -18.4) -11.8 (-13.1, -10.6) < 0.001
2D PLS (%)
Global*† -18.1 (-19.9, -16.2) -14.5 (-16.6, -12.4) -9.2 (-10.3, -8.1) 0.001
Data are presented as mean (95% confidence interval). *Statistical significance between groups 1 and 2, †Statistical significance 
between group 1 and the control group. PCS = peak circumferential strain, PLS = peak longitudinal strain, PRS = peak radial strain, 2D = 
two-dimensional
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heart specimens [11]. A previous study of patients with 
CA showed a significant relative apical sparing pattern on 
florbetapir positron emission tomography, which is a known 
marker of amyloid burden [35]. Another study revealed 
increased technetium 99m pyrophosphate uptake in the 
basal and mid LV segments compared with the apical LV 
segments in patients with TTR CA, suggesting that higher 
amyloid deposition in the basal and mid regions compared 
with the apical region is a cause of differential regional 
uptake [36]. Another study suggested that low basal strain 
values can help diagnose CA with high sensitivity (82.5%) 
and specificity (82.9%) [37]. 
This study has some limitations. First, it was a 
retrospective study and involved a small number of patients 
at a single center. Second, the EMB was performed in only 
17 patients. Third, CMR-FT has limitations of inter-vendor 
variability and a lack of standard normal values, which need 
further validation. Finally, we did not prove the regional 
amyloid deposition differences through histopathological 
examination, which is only possible with postmortem 
analysis.
In conclusion, quantitative T1 mapping parameters such 
as native T1 and ECV may help diagnose early CA. ECV, in 
particular, can reflect regional differences in the amyloid 
deposition in patients with advanced CA, and increased 
basal ECV is related to decreased basal strain. Therefore, 
using quantitative CMR parameters may help diagnose CA 
and determine the severity of CA in patients with or without 
LGE.
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However, LGE can be atypical or normal in patients with CA. 
Furthermore, choosing and nulling the normal myocardium 
on LGE images is difficult [32]. Therefore, mapping and ECV 
are emerging as objective quantitative methods with high 
accuracy for identifying CA [32].
Here, 8 out of 40 patients with CA (20%) exhibited focal 
patchy or no LGE (group 1). This group showed lower LV 
mass and LV wall thickness compared with the diffuse and 
global LGE group (group 2), indicative of early CA. 
Group 2 showed the well-known CA features of very high 
native T1 and ECV. Group 1 also showed significantly higher 
native T1 and ECV than the control group. Therefore, native 
T1 and ECV may be useful in diagnosing early CA, even 
when there is atypical or no LGE.
We found differences in the regional patterns of ECV and 
CMR strain values among the 3 groups. In group 2, basal 
ECV was significantly higher than mid and apical ECVs, 
which can be considered a “basal predominant pattern.” 
However, this pattern was not observed in group 1 or the 
control group. These findings indirectly reflect regional 
amyloid deposition differences because ECV is regarded 
as a marker of amyloid burden in CA, as amyloid fibrils 
are located in extracellular spaces [13,33]. This basal 
predominant pattern of ECV and strain may be characteristic 
of advanced CA; therefore, it might help classify the 
severity of CA. Furthermore, there was a significant negative 
correlation between ECV and strain parameters in the basal 
region in group 2, indicating that severe amyloid deposits 
in the basal regions result in deterioration of regional LV 
mechanical motion in advanced CA.
Additionally, we compared the mapping and ECV values 
between different types of amyloidosis. The TTR type has 
lower T1 and higher ECV with a more benign disease course 
than the AL type [8,18,34]. In our study, ECV was slightly 
higher in the TTR group than in the AL group; however, 
there was no statistical significance. Moreover, a significant 
interregional difference in terms of ECV was only observed 
in the AL group (p = 0.004). Because there were only 6 
patients in the TTR group, interpretation of this result 
should be done carefully. Future research with a larger 
population is needed. 
Regional pattern differences exist in patients with CA. A 
recent study of patients with advanced CA showed that LV 
LGE was most common in the basal region and correlated 
negatively with the mean longitudinal strain on ECG [11]. 
Histopathological findings also showed abundant amyloid 
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